Follow a patient on their ALK+ NSCLC treatment journey by joining us for an interactive patient case study with voting and panel discussion around the following topics: 1L treatment selection for ALK+ NSCLC; ALK TKI treatment initiation; response to ALK TKI therapy; therapy management, and progression on 1L treatment (ID 306)